AssetMark Inc
IONS icon

AssetMark Inc’s Ionis Pharmaceuticals IONS Stock Holding History

AssetMark Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$788K Buy
9,939
+365
+4% +$27.5K ﹤0.01% 1133
2026
Q1 		$719K Buy
9,574
+924
+11% +$72.9K ﹤0.01% 1096
2025
Q4 		$684K Buy
8,650
+8,575
+11,433% +$646K ﹤0.01% 1089
2025
Q3 		$4.91K Hold
75
– – ﹤0.01% 2348
2025
Q2 		$2.96K Buy
75
+60
+400% +$1.96K ﹤0.01% 2306
2025
Q1 		$453 Sell
15
-17
-53% -$557 ﹤0.01% 2435
2024
Q4 		$1.12K Buy
+32
New +$1.2K ﹤0.01% 2222
2024
Q2 		– Sell
-1
Closed -$43 – 2175
2024
Q1 		$43 Sell
1
-6
-86% -$286 ﹤0.01% 1848
2023
Q4 		$354 Buy
+7
New +$335 ﹤0.01% 1705
2022
Q4 		– Sell
-250
Closed -$11K – 1621
2022
Q3 		$11K Buy
+250
New +$10.5K ﹤0.01% 1213
2019
Q4 		– Sell
-25
Closed -$2K – 1428
2019
Q3 		$2K Hold
25
– – ﹤0.01% 1169
2019
Q2 		$2K Hold
25
– – ﹤0.01% 1166
2019
Q1 		$2K Hold
25
– – ﹤0.01% 1171
2018
Q4 		$1K Hold
25
– – ﹤0.01% 1319
2018
Q3 		$1K Hold
25
– – ﹤0.01% 1344
2018
Q2 		$1K Hold
25
– – ﹤0.01% 1343
2018
Q1 		$1K Sell
25
-46
-65% -$2.34K ﹤0.01% 1338
2017
Q4 		$4K Buy
71
+66
+1,320% +$3.62K ﹤0.01% 1292
2017
Q3 		$0 Buy
+5
New +$262 ﹤0.01% 1538

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AssetMark Inc's IONS Position: Q2 2026 in Review

AssetMark Inc increased its Ionis Pharmaceuticals (IONS) stake by 3.8% in Q2 2026, buying an estimated $27.5K and bringing the position to 9,939 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

AssetMark Inc first reported a position in IONS in Q3 2017 and has held it in 19 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • AssetMark Inc held 9,939 shares of Ionis Pharmaceuticals worth $788K as of Q2 2026.
  • AssetMark Inc bought 365 Ionis Pharmaceuticals shares in Q2 2026, an estimated $27.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1133 holding.
  • AssetMark Inc first reported a position in Ionis Pharmaceuticals in Q3 2017 and has held it in 19 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.